Ardelyx Inc

Ardelyx Inc

ARDX · NASDAQ
ARDX · NASDAQ
3.25
USD0.237.57%

Latest News

    SeekingAlpha

    Ardelyx gains on report Zydus Lifesciences in talks to purchase

      @Reuters
      Reuters

      Ardelyx sues US health department over kidney disease drug https://t.co/gdzWoUJlJ7 https://t.co/E07WomsKsD

        MarketWatch

        Ardelyx wins long battle for FDA approval of kidney-disease treatment

          @eWhispers
          eWhispers

          #earnings after the close https://t.co/lObOE0dgsr $QCOM $MELI $ETSY $ALB $SEDG $FSLY $RUN $MRO $APA $HUBS $TRIP $ZG $ARDX $MOS $O $LMND $PSA $UPWK $CFLT $ACLS $REI $QRVO $ALL $MET $VET $ESTE $VAC $YELL $EQIX $SITM $ASPN $HDSN $WMB $DHT $RELY $MKSI $CPE $JOBY $XPO $IR $UDMY… https://t.co/fhIjlzIUMC

            @Reuters
            Reuters

            U.S. FDA advisers back Ardelyx's kidney disease drug https://t.co/r9LASYcYaw https://t.co/DG5zdPj3Hr

              @Reuters
              Reuters

              U.S. FDA advisers back Ardelyx's kidney disease drug https://t.co/BuXxvvzLNd https://t.co/mwX3xtZjJ8

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              3.02USD
              3.25USD

              52 Week Range

              2.96USD
              8.40USD

              Market Cap

              782.31MUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US0396971071

              CUSIP

              039697107

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -0.08

              Book Value

              0.60

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -0.23

              Wall Street Target Price

              12.80

              EPS Estimate Current Year

              -0.19

              EPS Estimate Next Year

              0.29

              EPS Estimate Current Quarter

              -0.0496

              EPS Estimate Next Quarter

              0.043

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              450,894,016

              Gross Profit TTM

              338,279,008

              EBITDA

              -32,106,000

              Profit Margin

              -12.35%

              Return On Assets TTM

              -4.25%

              Return On Equity TTM

              -38.61%

              Revenue Per Share TTM

              1.841

              Qtly Revenue Growth YOY

              23.80%

              Diluted Eps TTM

              -0.23

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              8

              Price Sales TTM

              1.735

              Price Book MRQ

              5.2499

              Enterprise Value Revenue

              1

              Enterprise Value EBITDA

              130

              Peers analysis

              • argenx NV ADR
                ARGXargenx NV ADR

                903.08

                3.20%
              • Moderna Inc
                MRNAModerna Inc

                227.40

                2.97%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                965.00

                0.55%
              • UCB SA
                UCBJFUCB SA

                314.92

                0.35%
              • argenx SE
                ARGNFargenx SE

                900.30

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                139.16

                0.00%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                528.21

                -4.77%
              • Be
                ONCBeiGene, Ltd.

                355.10

                -2.26%
              • CSL Ltd
                CSLLYCSL Ltd

                34.64

                -2.01%
              • UCB SA ADR
                UCBJYUCB SA ADR

                153.70

                -1.47%

              FAQs

              What is Ardelyx stock price today?

              What is Ardelyx stock ticker?

              Is ARDX stock price going up?

              What is the analyst recommendation for ARDX?

              What is ARDX market cap?

              Does ARDX release financial reports?

              When is ARDX next earnings date?

              What were ARDX Earnings for the last quarter?

              What was ARDX Revenue for the last quarter?

              What was ARDX Net Income for the last quarter?

              Does ARDX pay dividends?

              How many employees does ARDX have?

              What is ARDX EBITDA?

              How to buy ARDX stocks?

              Should I invest in ARDX stock?